Daniel James Wilks

Prof. Daniel James Wilks

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2010 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
RWRobert I.S. Mbbs Winterton
Robert I.S. Mbbs Winterton
DWDaniel James Wilks
Daniel James Wilks
PCPaul D. Mbbs Chumas
Paul D. Mbbs Chumas
JRJohn L. MBChB Russell
John L. MBChB Russell
MLMark I. Mb Liddington
Mark I. Mb Liddington
Nasal dermoid sinus cysts (NDSCs) are rare congenital anomalies affecting approximately 1 in 30,000 live births. Nasal dermoid sinus cysts are unsightly, prone to infection, and, importantly, may communicate with the central nervous system. Treatment is complete surgical excision. This study retrospectively evaluated management of a large single-center cohort of intracranial NDSCs. Nineteen patients with NDSC were identified from all patients presenting to the Leeds craniofacial service between June 2000 and August 2008. Patient demographics, clinical presentation, preoperative investigations, and surgical procedures undertaken were analyzed. Mean age at presentation and surgery were 6.3 and 7.6 years, respectively. Fifty-three percent were males. Computed tomography (CT) and magnetic resonance imaging (MRI) were performed in 15 and 17 patients, respectively. One patient (5.3%) required local excision only. Eighteen (96.7%) underwent a bicoronal approach, and 13 (68.4%) of these required a craniotomy. The dura was opened in 7 (36.8%) patients. Neither CT nor MRI predicted the presence or absence of intracranial extension in all patients. Positive and negative predictive values for intracranial extension were 85.7% and 50% for CT and were 100% and 50.0% for MRI. Mean follow-up of 4.1 years shows no deep recurrences and 5 (26.3%) were superficial nasal recurrences only. A multidisciplinary approach can achieve good results with infrequent intracranial recurrence. We used a bicoronal approach to facilitate craniotomy when required intraoperatively because imaging is unable to diagnose intracranial extension with sufficient accuracy.

1 August 2012 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
DWDaniel James Wilks
Daniel James Wilks
SKS.P.J. Kay
S.P.J. Kay
GBG. Bourke
G. Bourke

1 October 2019 in Transplantation
Verified
Journal Article
Closed access
EBErik Berglund
Erik Berglund
MLMette Andersen Ljungdahl
Mette Andersen Ljungdahl
DBDarko Bogdanović
Darko Bogdanović
DBDavid Berglund
David Berglund
JWJonas Wadström
Jonas Wadström
SSStefan Schneeberger
Stefan Schneeberger
Background.: Donor-specific antibodies (DSAs) have a strong negative correlation with long-term survival in solid organ transplantation. Although the clinical significance of DSA and antibody-mediated rejection (AMR) in upper extremity transplantation (UET) remains to be established, a growing number of single-center reports indicate their presence and potential clinical impact. Methods.: We present a multicenter study assessing the occurrence and significance of alloantibodies in UET in reference to immunological parameters and functional outcome. Results.: Our study revealed a high prevalence and early development of de novo DSA and non-DSA (43%, the majority detected within the first 3 postoperative y). HLA class II mismatch correlated with antibody development, which in turn significantly correlated with the incidence of acute cellular rejection. Cellular rejections preceded antibody development in almost all cases. A strong correlation between DSA and graft survival or function cannot be statistically established at this early stage but a correlation with a lesser outcome seems to emerge. Conclusions.: While the phenotype and true clinical effect of AMR remain to be better defined, the high prevalence of DSA and the correlation with acute rejection highlight the need for optimizing immunosuppression, close monitoring, and the relevance of an HLA class II match in UET recipients.

1 February 2004 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
DWDaniel James Wilks
Daniel James Wilks
AHAlastair W.M Hay
Alastair W.M Hay

1 November 2013 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
SKSimon Kay
Simon Kay
DWDaniel James Wilks
Daniel James Wilks

15 May 2023 in Journal of Pediatric Orthopaedics
Verified
Journal Article
Closed access
DWDaniel James Wilks
Daniel James Wilks
XYXuan Mbbs Ye
Xuan Mbbs Ye
RBRose Msc Biggins
Rose Msc Biggins
KWKemble K. Mbbs Wang
Kemble K. Mbbs Wang
RWRyckie G. Wade
Ryckie G. Wade
DMDavid McCombe
David McCombe
Background: Management of supracondylar humerus fractures (SCHF) with coexisting median nerve injury is controversial. Although many nerve injuries improve with the reduction and stabilization of the fracture, the speed and completeness of recovery are unclear. This study investigates median nerve recovery time using the serial examination. Methods: A prospectively maintained database of SCHF-related nerve injuries referred to a tertiary hand therapy unit between 2017 and 2021 was interrogated. Factors related to the injury (vascularity, Gartland grade, open vs. closed fracture) and treatment (fixation modality, adequacy, timing of reduction, vascular and nerve intervention, and secondary procedures) were assessed. Primary outcomes were the motor recovery of Medical Research Council (MRC) grade 4 or 5 in flexor pollicis longus or flexor digitorum profundus (index) and detection of the 2.83 Semmes Weinstein monofilament. A retrospective clinical note review of all SCHF presenting during the same period was also conducted. Results: Of 1096 SCHF, 74 (7%) had an associated median nerve palsy. Twenty-one patients [mean age 7 years (SD 1.6)] with SCHF-related median nerve injuries underwent serial examination. Nineteen (90%) were modified Gartland III or IV, and 10 (48%) were pulseless on presentation. The mean follow-up was 324 days. The mean motor recovery time was 120 days (SD 71). Four (27%) and 2 (13%) patients had not achieved MRC grade 4 by 6 months and 2 years, respectively. Only 50% attained MRC grade 5 at 2 years. When compared with closed reduction, those who underwent open reduction recovered motor function 80 days faster (mean 71 vs. 151 d, P=0.03) and sensory function 110 days faster (52 vs. 162, P=0.02). Fewer patients recovered after closed reduction (8 of 10) than open (5 of 5). Modified Gartland grade, vascular status, adequacy of reduction, and secondary surgery were not associated with recovery time. Conclusions: Median nerve recovery seems to occur slower than previously thought, is often incomplete, and is affected by treatment decisions (open vs. closed reduction). Retrospective reporting methods may overestimate median nerve recovery. Level of Evidence: Level III—therapeutic.